The AHA, joined by the Association of American Medical Colleges, Federation of American Hospitals, Hospital and Healthsystem Association of Pennsylvania and New Jersey Hospital Association, today urged the U.S. Supreme Court to review a 3rd Circuit Court of Appeals decision that gives private individuals “broad license” to bring meritless False Claims Act lawsuits against hospitals and other health care providers. 

“This case presents a question of tremendous importance: whether a plaintiff can plausibly allege a violation of the False Claims Act by claiming that the defendant knowingly violated an ambiguous regulatory provision that has not been definitively construed prior to that defendant’s case,” in this case the Stark Act, the groups said in a friend-of-the-court brief. “…If all a qui tam relator needs to do to survive a motion to dismiss is allege that a hospital violated an ambiguous statute or regulation, then hospitals will routinely face years of FCA litigation, millions of dollars of costs, and immense pressures to settle.”

In the case, U.S. ex rel. Bookwalter v. UPMC, a 3rd Circuit panel reversed a lower court’s decision dismissing an FCA case against the University of Pittsburgh Medical Center that involved productivity-based physician compensation structures between UPMC’s subsidiary physician practices and neurosurgeons.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…